These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38561456)
1. LncRNA GAS5 restrains ISO-induced cardiac fibrosis by modulating mir-217 regulation of SIRT1. Zhang YH; Sun TT; Liu ZH; Li X; Fan XF; Han LP Sci Rep; 2024 Apr; 14(1):7652. PubMed ID: 38561456 [TBL] [Abstract][Full Text] [Related]
2. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR. Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444 [TBL] [Abstract][Full Text] [Related]
3. LncRNA GAS5 inhibits miR-579-3p to activate SIRT1/PGC-1α/Nrf2 signaling pathway to reduce cell pyroptosis in sepsis-associated renal injury. Ling H; Li Q; Duan ZP; Wang YJ; Hu BQ; Dai XG Am J Physiol Cell Physiol; 2021 Jul; 321(1):C117-C133. PubMed ID: 34010066 [TBL] [Abstract][Full Text] [Related]
4. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy. Che H; Wang Y; Li H; Li Y; Sahil A; Lv J; Liu Y; Yang Z; Dong R; Xue H; Wang L FASEB J; 2020 Apr; 34(4):5282-5298. PubMed ID: 32067273 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA GAS5 inhibits cell proliferation and fibrosis in diabetic nephropathy by sponging miR-221 and modulating SIRT1 expression. Ge X; Xu B; Xu W; Xia L; Xu Z; Shen L; Peng W; Huang S Aging (Albany NY); 2019 Oct; 11(20):8745-8759. PubMed ID: 31631065 [TBL] [Abstract][Full Text] [Related]
6. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts. Cáceres FT; Gaspari TA; Samuel CS; Pinar AA FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135 [TBL] [Abstract][Full Text] [Related]
7. DNMT1 Methylation of LncRNA GAS5 Leads to Cardiac Fibroblast Pyroptosis via Affecting NLRP3 Axis. She Q; Shi P; Xu SS; Xuan HY; Tao H; Shi KH; Yang Y Inflammation; 2020 Jun; 43(3):1065-1076. PubMed ID: 32008164 [TBL] [Abstract][Full Text] [Related]
8. lncRNA GAS5 promotes pyroptosis in COPD by functioning as a ceRNA to regulate the miR‑223‑3p/NLRP3 axis. Mo R; Li J; Chen Y; Ding Y Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35583006 [TBL] [Abstract][Full Text] [Related]
9. LncRNA GAS5 protects against TGF-β-induced renal fibrosis via the Smad3/miRNA-142-5p axis. Zhang YY; Tan RZ; Yu Y; Niu YY; Yu C Am J Physiol Renal Physiol; 2021 Oct; 321(4):F517-F526. PubMed ID: 34486400 [TBL] [Abstract][Full Text] [Related]
10. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. Chen T; Meng Y; Zhou Z; Li H; Wan L; Kang A; Guo W; Ren K; Song X; Chen Y; Zhao W Cell Death Differ; 2023 Jul; 30(7):1829-1848. PubMed ID: 37337032 [TBL] [Abstract][Full Text] [Related]
11. LncRNA GAS5 exacerbates renal tubular epithelial fibrosis by acting as a competing endogenous RNA of miR-96-5p. Wang W; Jia YJ; Yang YL; Xue M; Zheng ZJ; Wang L; Xue YM Biomed Pharmacother; 2020 Jan; 121():109411. PubMed ID: 31810140 [TBL] [Abstract][Full Text] [Related]
12. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3. Liao H; Zhang S; Qiao J Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284 [TBL] [Abstract][Full Text] [Related]
13. Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome. Wan Y; Xu L; Wang Y; Tuerdi N; Ye M; Qi R Eur J Pharmacol; 2018 Aug; 833():545-554. PubMed ID: 29913124 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p. Xu W; Zhang L; Geng Y; Liu Y; Zhang N Int Immunopharmacol; 2020 Aug; 85():106614. PubMed ID: 32470877 [TBL] [Abstract][Full Text] [Related]
15. LncRNA Yang Z; Lin SD; Zhan F; Liu Y; Zhan YW Autoimmunity; 2021 Feb; 54(1):13-22. PubMed ID: 33215529 [TBL] [Abstract][Full Text] [Related]
16. LncRNA GAS5 suppresses inflammatory responses by inhibiting HMGB1 release via miR-155-5p/SIRT1 axis in sepsis. Zeng Z; Lan Y; Chen Y; Zuo F; Gong Y; Luo G; Peng Y; Yuan Z Eur J Pharmacol; 2023 Mar; 942():175520. PubMed ID: 36693551 [TBL] [Abstract][Full Text] [Related]
17. A novel mechanism regulating pyroptosis-induced fibrosis in endometriosis via lnc-MALAT1/miR-141-3p/NLRP3 pathway†. Xu Y; Liu H; Xiong W; Peng Y; Li X; Long X; Jin J; Liang J; Weng R; Liu J; Zhang L; Liu Y Biol Reprod; 2023 Aug; 109(2):156-171. PubMed ID: 37233993 [TBL] [Abstract][Full Text] [Related]
18. DNMT1 methylation of LncRNA-ANRIL causes myocardial fibrosis pyroptosis by interfering with the NLRP3/Caspase-1 pathway. Liu Z; Gao L; Kan C; Chen X; Shi K; Wang W Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):197-203. PubMed ID: 38650132 [TBL] [Abstract][Full Text] [Related]
19. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis. Kang H; Yu H; Zeng L; Ma H; Cao G Hypertens Res; 2022 Jun; 45(6):976-989. PubMed ID: 35264782 [TBL] [Abstract][Full Text] [Related]
20. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway. Ding S; Liu D; Wang L; Wang G; Zhu Y J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]